MENU

Earnings season week five preview

Earnings season may come to an end this week but there’s still plenty for investors to look out for.

Here is a preview of week five:

Monday.

This morning results are expected to be released from telco company Amaysim Australia Ltd (ASX: AYS), struggling child care operator G8 Education Ltd (ASX: GEM), fertility treatment company Monash IVF Group Ltd (ASX: MVF), and broadband equipment manufacturer Netcomm Wireless Ltd (ASX: NTC).

I’ll be looking out for improvements in Amaysim’s ARPU, G8 Education’s occupancy levels, and trading conditions for Monash IVF. The market will no doubt be expecting a strong result from Netcomm Wireless after it delivered an impressive half year result which saw revenue rise 89% to $88.6 million.

Tuesday.

Three big results are due to be released on Tuesday from fast-growing tech star Appen Ltd (ASX: APX), health supplements company Blackmores Limited (ASX: BKL), and fuel retailer Caltex Australia Limited (ASX: CTX). According to the Bloomberg consensus estimate, the market is looking for NPAT of 70.7 million from Blackmores in FY 2018.

Elsewhere, I feel there’s a reasonably strong chance that Appen will upgrade its full year guidance when it releases its half year results. I expect this to be driven by strong demand from the machine learning market and favourable currency movements.

Wednesday.

Wednesday is expected to be a busy day with releases pencilled in for game technology company Ainsworth Game Technology Limited (ASX: AGI), infant formula star Bellamy’s Australia Ltd (ASX: BAL), building materials company Boral Limited (ASX: BLD), personal care products company BWX Ltd (ASX: BWX), telecom and cloud services company Macquarie Telecom Group Ltd (ASX: MAQ), regenerative medicine company Sirtex Medical Limited (ASX: SRX) and airline Virgin Australia Holdings Ltd (ASX: VAH).

According to the Bloomberg consensus estimate, the market expects NPAT of $45.7 million from Bellamy’s. However, all eyes will be on its guidance and an update on its CFDA application.

Thursday.

It looks set to be a quieter day on Thursday with just three releases scheduled. These include struggling private hospital operator Ramsay Health Care Limited (ASX: RHC), casino operator Donaco International Ltd (ASX: DNA), and financial services company Perpetual Limited (ASX: PPT).

In respect to the Ramsay result, investors will be focused on its guidance for the year ahead and whether trading conditions have improved.

Friday.

The week finishes with results releases from plumbing parts company Reece Ltd (ASX: REH) and data centre operator NEXTDC Ltd (ASX: NXT). The latter is not expected to deliver a strong profit result due to its increased investment in its data centres to fuel future growth. But investors will be expecting the company to report a strong increase in demand for its data centre services to back up its substantial increase in capacity.

Not sure which shares to pick up? Check out these market beaters.

Top 3 ASX Blue Chips To Buy In 2018

For many, blue chip stocks mean stability, profitability and regular dividends, often fully franked..

But knowing which blue chips to buy, and when, can be fraught with danger.

The Motley Fool’s in-house analyst team has poured over thousands of hours worth of proprietary research to bring you the names of "The Motley Fool’s Top 3 Blue Chip Stocks for 2018."

Each one pays a fully franked dividend. Each one has not only grown its profits, but has also grown its dividend. One increased it by a whopping 33%, while another trades on a grossed up (fully franked) dividend yield of almost 7%.

The names of these Top 3 ASX Blue Chips are included in this specially prepared free report. But you will have to hurry. Depending on demand – and how quickly the share prices of these companies moves – we may be forced to remove this report.

Click here to claim your free report.

Motley Fool contributor James Mickleboro owns shares of NEXTDC Limited. The Motley Fool Australia owns shares of and has recommended Blackmores Limited and BWX Limited. The Motley Fool Australia owns shares of Appen Ltd. The Motley Fool Australia has recommended Monash IVF Group Ltd and Ramsay Health Care Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

Two New Stock Picks Every Month!

Not to alarm you, but you’re about to miss a very important event! Chief Investment Advisor Scott Phillips and his team at Motley Fool Share Advisor are about to reveal their latest official stock recommendation. The premium “buy alert” will be unveiled to members and you can be among the first to act on the tip.

Don’t let this opportunity pass you by – this is your chance to get in early!

Simply enter your email now to find out how you can get instant access.

By clicking this button, you agree to our Terms of Service and Privacy Policy. We will use your email address only to keep you informed about updates to our website and about other products and services we think might interest you. You can unsubscribe from Take Stock at anytime. Please refer to our Financial Services Guide (FSG) for more information.